No significant news for in the past two years. CPRX is not currently paying a regular dividend. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements.
Is Catalyst Pharmaceuticals Inc (cprx) a good investment?
CATALYST PHARMACEUTICALS INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low. CPRX: What does Argus have to say about CPRX?
How did catalyst (cprx) perform in the quarter ended June 2023?
Catalyst (CPRX) delivered earnings and revenue surprises of 32% and 7.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
